Pathogenesis of HIV-1 protease inhibitor-associated partial lipodystrophy: An ultrastructural study

被引:0
|
作者
Lloreta, J
Domingo, P
Pujol, RM
Baixeras, N
Matias-Guiu, X
Serrano, S
机构
[1] Univ Pompeu Fabra, Barcelona, Spain
[2] Autonomous Univ Barcelona, Barcelona, Spain
[3] IMIM, IMAS, Hosp Mar, Barcelona, Spain
[4] Hosp Sant Pau, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1407
引用
收藏
页码:238A / 238A
页数:1
相关论文
共 50 条
  • [31] Interdependence of Inhibitor Recognition in HIV-1 Protease
    Paulsen, Janet L.
    Leidner, Florian
    Ragland, Debra A.
    Yilmaz, Nese Kurt
    Schiffer, Celia A.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2017, 13 (05) : 2300 - 2309
  • [32] THE STRUCTURES OF INHIBITOR COMPLEXES OF HIV-1 PROTEASE
    WLODAWER, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 82 - MEDI
  • [33] Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease
    Davis, David A.
    Brown, Cara A.
    Singer, Kathleen E.
    Wang, Victoria
    Kaufman, Joshua
    Stahl, Stephen J.
    Wingfield, Paul
    Maeda, Kenji
    Harada, Shigeyoshi
    Yoshimura, Kazuhisa
    Kosalaraksa, Pope
    Mitsuya, Hiroaki
    Yarchoan, Robert
    ANTIVIRAL RESEARCH, 2006, 72 (02) : 89 - 99
  • [34] Protease inhibitor-associated hypertriglyceridemia and diabetes mellitus in HIV-infected patients
    Knobel, H
    Goday, A
    Grau, S
    MEDICINA CLINICA, 1998, 111 (15): : 599 - 599
  • [35] Liposuction for protease-inhibitor-associated lipodystrophy
    Ponce-de-Leon, S
    Iglesias, M
    Ceballos, J
    Ostrosky-Zeichner, L
    LANCET, 1999, 353 (9160): : 1244 - 1244
  • [36] Peripheral lipodystrophy associated with protease inhibitor therapy
    de Vega, EC
    Gómez, BJF
    Arnau, RS
    Clotet, EP
    REVISTA CLINICA ESPANOLA, 1999, 199 (08): : 546 - 547
  • [37] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Axel Fun
    Noortje M van Maarseveen
    Jana Pokorná
    Renée EM Maas
    Pauline J Schipper
    Jan Konvalinka
    Monique Nijhuis
    Retrovirology, 8
  • [38] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Fun, Axel
    van Maarseveen, Noortje M.
    Pokorna, Jana
    Maas, Renee E. M.
    Schipper, Pauline J.
    Konvalinka, Jan
    Nijhuis, Monique
    RETROVIROLOGY, 2011, 8
  • [39] Pathogenesis of HIV-1 associated neurodegeneration
    Masliah, E
    Ge, NF
    Mucke, L
    CRITICAL REVIEWS IN NEUROBIOLOGY, 1996, 10 (01): : 57 - 67
  • [40] Predictors of protease inhibitor-associated adverse events
    Bonfanti, P
    Ricci, E
    Landonio, S
    Valsecchi, L
    Timillero, L
    Faggion, I
    Quirino, T
    BIOMEDICINE & PHARMACOTHERAPY, 2001, 55 (06) : 321 - 323